JP Morgan Raises MetLife (MET) Price Target to $110

JP Morgan has reiterated its Overweight rating on MetLife, Inc. with a new price target of $110 on October 15, 2026, a 8.18% upside from the current price.

By EarningsIQ Research Desk · Published Oct 15, 2026, 9:18 PM EDT · Updated Oct 16, 2026, 8:15 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

JP Morgan raised its price target on MetLife, Inc. ($MET) to $110 from $108 on October 15, 2026, and rates the stock "Overweight".

Since the rating, $MET is up 0.5% to date (from the $100.27 close on Oct 15, 2026).

MET MetLife, Inc.

$100.76 +28.11% year to date

Daily close · Oct 16, 2026

Key Points

JP Morgan maintains its Overweight rating on MetLife, Inc. (NYSE: MET) and adjusted the price target to $110, up from $108.
JP Morgan's $110 price target implies 8.18% upside from MetLife, Inc.'s ($MET) current $101.69 share price.
As of October 16, 2026, MetLife shares were recently trading around $101.69, which is about 7.6% below the analyst's new target.
The company reported a trailing twelve-month revenue of approximately $79.4 billion and an earnings per share (EPS) of $5.22.

Get $MET trade alerts by text

We text you when insiders, Congress or big funds trade $MET. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated MetLife, Inc. alert may contain errors. Disclosures

JP Morgan has reiterated its Overweight rating on MetLife, Inc. (NYSE: MET) with a price target of $110 on October 15, 2026. This is an increase from the prior target of $108. The firm believes the stock has potential for growth despite its current trading position.

Analyst rating track record

JP Morgan vs. the S&P 500

YTD return -1.44% hypothetical

All-time return -1.44% S&P 500 +0.45%

vs. S&P 500 -1.89% behind the index

Hypothetical returns from JP Morgan's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in MetLife

Several other institutional investors have also adjusted their positions in MetLife. Blackrock Inc. grew its holdings by 365,095 shares, now holding 51,786,925 shares worth about $5.2 billion. Meanwhile, Dodge & Cox Inc. trimmed its stake by 2,683,520 shares, leaving it with 48,431,150 shares valued at approximately $4.9 billion. Vanguard Capital Management LLC decreased its position as well, with a reduction of 372,910 shares, totaling 35,483,789 shares worth about $3.6 billion. Additionally, Vanguard Portfolio Management LLC cut its holdings by 782,678 shares, ending with 30,031,431 shares valued at around $3.0 billion. State Street Corporation made a slight increase, adding 116,017 shares for a total of 25,336,999 shares valued at about $2.6 billion.

MetLife, Inc. Stock Up 1.4%

MetLife shares were recently trading around $101.69 as of October 16, 2026, which places them about 7.6% below the analyst's target of $110. This target suggests there may be room for growth, especially considering the company's robust revenue figures and its standing in the financial services sector.

12-month forecast

$MET price target

MetLife, Inc. daily closes and this analyst's $110 target. Not advice.

Recent Earnings

For the trailing twelve months, MetLife reported revenue of approximately $79.4 billion and earnings per share (EPS) of $5.22. The company is scheduled to announce its next earnings on November 9, 2026, which could influence future analyst ratings and investor sentiment.

Analysts Set New Price Targets

On October 6, 2026, UBS maintained its Buy rating on MetLife with a price target of $110, up from $105. Mizuho also maintained its Outperform rating with a target of $109, down from $112 on October 7, 2026. Barclays kept its Overweight rating, increasing its target to $111 from $97 on the same day. Wells Fargo maintained its Overweight rating with a price target of $110, up from $109 on October 12, 2026. The consensus among analysts suggests a positive outlook for MetLife, with a mean price target of $110 from multiple firms.

About MetLife, Inc.

MetLife, Inc. is a leading financial services company that offers a wide range of insurance products, annuities, employee benefits, and asset management services globally. The company operates through various segments, including Group Benefits and Retirement Solutions. With its substantial revenue and diverse offerings, MetLife is well-positioned in the financial services sector.

Bottom Line

Investors should keep an eye on MetLife's upcoming earnings report on November 9, 2026, as it may influence future analyst ratings and stock performance. With JP Morgan's reiterated Overweight rating and adjusted price target, the market will be watching closely for any developments that could affect the company's outlook.